National Healthcare Properties, Inc. annual report, FY2020

Business Context and Reporting Period

The filing is Healthcare Trust, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020. The request metadata refers to National Healthcare Properties, Inc., but the filing identifies the registrant as Healthcare Trust, Inc.

Healthcare Trust is an externally managed healthcare REIT focused on medical office buildings, triple-net healthcare facilities and seniors housing operating properties. At year-end, it owned 193 properties in 31 states totaling 9.4 million rentable square feet, with gross asset value of approximately $2.6 billion.

  • Medical office and outpatient: 117 properties, 3.9 million square feet, 41.8% of gross asset value.
  • Triple-net leased healthcare: 15 properties, 1.1 million square feet, 10.8% of gross asset value.
  • Seniors housing operating properties: 61 properties, 4.4 million square feet, 47.4% of gross asset value.

Financial Performance and Key Metrics

Metric20202019Change
Revenue from tenants$381.6 million$374.9 million1.8% increase
Total operating expenses$406.7 million$415.5 million2.1% decrease
Operating loss$19.9 million$31.8 millionImproved by $11.9 million
Net loss$75.5 million$88.3 millionImproved by $12.8 million
Net loss attributable to common stockholders$78.8 million$88.1 millionImproved by $9.3 million
Basic and diluted loss per share$0.83 loss$0.93 lossImproved by $0.10
Cash flow from operations$41.8 million$47.4 million12% decrease
FFO attributable to common stockholders$31.6 million$38.2 million17.5% decrease
MFFO attributable to common stockholders$34.3 million$32.2 million6.5% increase
NOI$138.1 million$140.7 million1.9% decrease

Reported revenue increased modestly, but underlying property performance was pressured by the COVID-19-related decline in seniors housing occupancy and higher operating costs. NOI declined primarily because same-store SHOP NOI fell $12.5 million, partially offset by a $4.8 million increase in MOB NOI and a $1.4 million increase in triple-net NOI.

Balance sheet and leverageDecember 31, 2020
Total assets$2.29 billion
Total equity$961.4 million
Gross debtApproximately $1.2 billion
Net debtApproximately $1.2 billion
Net debt to gross asset valueApproximately 44.5%
Cash and cash equivalents$72.4 million
Revolving credit availability$48.3 million
Weighted-average interest rate on gross debt3.58%

Cash flows used in investing were $82.5 million, including $95.0 million for acquisitions and $21.9 million of capital expenditures, partially offset by $34.4 million of property-sale proceeds. Financing cash flow was $19.4 million, including $95.0 million of revolving-credit borrowings and $31.4 million of cash distributions to common stockholders.

Material Changes Versus the Prior Comparable Period

  • SHOP occupancy declined from 85.7% at December 31, 2019 to 75.1% at December 31, 2020. Same-store SHOP revenue decreased $8.8 million and same-store SHOP NOI decreased $12.5 million.
  • SHOP operating costs increased due to labor, services, personal protective equipment and other pandemic-related expenses. COVID-19 costs totaled $7.6 million for same-store properties, partially offset by $3.6 million of CARES Act grants.
  • MOB NOI increased $4.8 million, including a $2.7 million same-store increase and a $2.5 million contribution from acquisitions.
  • Impairment charges decreased to $36.4 million from $56.0 million. The 2020 charges included $19.6 million related to Michigan SHOPs and $16.9 million related to the Jupiter and Wellington, Florida properties.
  • Interest expense declined to $51.5 million from $56.1 million, reflecting lower interest rates and the absence of a $3.0 million deferred-financing-cost write-off recorded in 2019.
  • The Company acquired nine properties for an aggregate contract purchase price of approximately $110.7 million and sold nine properties for approximately $40.4 million.
  • Common-stock distributions changed from cash to stock beginning in the fourth quarter of 2020. The Company declared stock dividends equal to 0.01349 shares per common share on October 1, 2020 and January 4, 2021.
  • The Company’s Series A Preferred Stock generated cumulative dividends of $1.84 per share annually, equivalent to a 7.375% rate on its $25.00 liquidation preference.
  • Common-share repurchases were suspended in August 2020 under the amended credit facility. The Company repurchased 505,101 shares for $8.8 million before the suspension.

Guidance, Outlook, Risks and Unusual Items

Management did not provide formal earnings or occupancy guidance. Management expects capital expenditures in 2021 to be generally similar to 2020 by segment and expects sufficient liquidity to meet obligations for at least the next 12 months, subject to COVID-19 effects, property operations and pending dispositions.

  • COVID-19: Management expects occupancy may stabilize or improve as infections decline and vaccinations increase, but stated that a return to pre-pandemic occupancy is uncertain. The Company received an additional $5.1 million of CARES Act funding on March 8, 2021.
  • Credit facility restrictions: Until a qualifying commencement quarter, no earlier than the quarter ending June 30, 2021, the Company generally cannot pay cash distributions on or repurchase common stock. Capital-event proceeds must generally be used to repay the revolving facility.
  • Liquidity: The Company must maintain at least $50.0 million of combined cash, cash equivalents and revolving availability. To resume common-stock cash distributions, it must meet a $100.0 million liquidity threshold and a consolidated debt-to-total-asset-value ratio below 62.5%, among other conditions.
  • Debt maturities: The revolving facility matures in March 2023, the term loan in March 2024, and the Fannie Mae facilities in November 2026. The filing shows approximately $179.3 million of debt principal scheduled in 2024 and $155.6 million in 2025.
  • Interest-rate risk: Nine swaps with a $578.5 million notional amount hedge part of variable-rate debt. A 100-basis-point increase in unhedged variable rates would increase annual interest expense by approximately $4.8 million.
  • Pending sales: The Company agreed to sell the Jupiter property for $65.0 million and the Wellington skilled nursing facility for $33.0 million. Closing is subject to conditions and is not assured; proceeds must be used to repay the revolving facility.
  • Tenant and legal exposure: The LaSalle tenants remained in default, with $12.7 million of rent, taxes, fees and interest receivable plus $7.7 million of court-awarded damages, all fully reserved.
  • Unusual items: The Company recorded a $4.6 million valuation allowance against deferred tax assets, $2.2 million of related-party severance and legal-cost reimbursements, and $36.4 million of real estate impairment charges.
  • Structural risks: The common stock has no established public market. The Company is externally managed by affiliates of AR Global and incurred $23.9 million of operating fees to related parties in 2020.

Most Important Facts for Investors to Verify

  • Confirm the registrant’s legal identity, because the supplied metadata names National Healthcare Properties, Inc., while the filing is for Healthcare Trust, Inc.
  • Verify the sustainability of SHOP occupancy, resident revenue, operating costs and NOI after the COVID-19 pandemic and expiration or reduction of government support.
  • Review credit-facility amendments, covenant calculations, liquidity thresholds and restrictions on common-stock cash distributions and repurchases.
  • Assess refinancing and interest-rate risk for the 2023–2026 maturities, including the transition away from LIBOR.
  • Confirm closing status and expected proceeds for the Jupiter and Wellington dispositions and the required application of proceeds to debt repayment.
  • Evaluate the collectability and legal status of the fully reserved LaSalle receivables and damages.
  • Reconcile GAAP net loss, FFO, MFFO and NOI; the filing cautions that non-GAAP measures are not substitutes for net income or operating cash flow.
  • Review related-party fees, reimbursements, advisory-agreement termination provisions and potential conflicts of interest.
  • Obtain the updated December 31, 2020 Estimated Per-Share NAV; the filing states that the prior published NAV was $15.75 as of December 31, 2019 and that no updated value was provided in the filing text.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.